Target intelligence / Profile preview

Physiological plasma proteins and growth factors

Molecular classification
Protein, Growth factor, Cytokine, Enzyme, Transport protein, Other
01

Overview

Physiological plasma proteins and growth factors represent a broad and heterogeneous class of endogenous molecules circulating in the blood that are vital for systemic homeostasis. Plasma proteins include high-abundance transport proteins like albumin, which maintains oncotic pressure and carries various hydrophobic molecules, as well as specialized proteins involved in the coagulation cascade and the innate immune system (StatPearls: Plasma Protein Binding). Growth factors are a subset of signaling proteins, such as vascular endothelial growth factor (VEGF) and fibroblast growth factors (FGFs), that regulate critical cellular processes including proliferation, differentiation, and tissue repair (NCBI: Growth Factors and Cytokines). In a pharmacological context, these molecules are significant both as therapeutic agents, such as recombinant growth factors or plasma-derived immunoglobulins, and as factors influencing drug pharmacokinetics through protein binding (PubChem: Albumin). Because this entry describes a functional category rather than a specific molecular entity, it is considered a grouping of multiple distinct targets and physiological components.

Other names
Plasma proteinsSerum proteinsCirculating growth factorsBlood proteinsPlasma-derived factors
02

Mechanism of action

These molecules operate through diverse mechanisms: transport proteins like albumin bind and distribute ligands; clotting factors act as enzymes in proteolytic cascades; and growth factors function as ligands that activate specific cell-surface receptors to initiate signal transduction (StatPearls: Physiology, Albumin; NCBI: Growth Factors).

03

Biological functions

HomeostasisBlood coagulationImmune responseCell signalingTransport of metabolitesWound healing
04

Disease associations

CoagulopathyInflammationCancerImmunodeficiencyCardiovascular disease
05

Safety considerations

Immunogenicity and antibody formationInfusion-related reactionsThrombotic eventsVolume overloadRisk of pathogen transmission in plasma-derived products
06

Interacting drugs

Warfarin

6 more in the full profile.

07

Biomarkers

Serum albumin levelC-reactive protein (CRP)D-dimerProthrombin time (PT)Vascular endothelial growth factor (VEGF) concentration

Beyond the preview

Go deeper on Physiological plasma proteins and growth factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological plasma proteins and growth factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call